The Fund will invest in a diversified portfolio of UK entrepreneurial growth companies while benefitting from the generous tax incentives offered by the government as part of the EIS.
The Calculus VCT has a strong track record of delivering regular dividends to investors. Investors also enjoy tax reliefs including income tax relief of up to 30% and tax free dividends.
Creative Content EIS Fund
The Fund will invest in a diversified portfolio of growth orientated, UK creative content companies while benefitting from the generous tax incentives offered by the government as part of the EIS.
Calculus Capital has over 20 years’ experience investing in diversified small and medium sized companies via the Calculus EIS and VCT.
The Calculus Creative Content EIS Fund is established to invest in independent content creation companies in the screen industries which are committed to long term growth and development.
Meet the company: Axol Bioscience
Axol Bioscience provides human cell culture systems and custom services to large pharmaceutical clients for disease modelling and drug discovery
@Spectral_MD has announced the commitment of additional funding of $18.8 million from the US Biomedical Advanced Research and Development Authority (BARDA), to help expand the clinical training study of their DeepView® Wound Imaging System for burn wound healing assessment. https://t.co/JO6zXLVJep